For the first time in biopharma history, a company has topped the $100 billion mark in annual revenue. Pfizer passed that milestone, propelled by its massive haul from its COVID-19 products. Its BioNTech-partnered vaccine, Comirnaty, raked in $37.8 billion, and oral antiviral Paxlovid made $18.9 billion. With its windfall, Pfizer displaced Johnson & Johnson as the industry’s No. 1 revenue generator. J&J had occupied that position for a decade and had been closing in on the $100 billion mark.
Read the full article: The Top 20 Pharma Companies by 2022 Revenue //
Source: https://www.fiercepharma.com/pharma/top-20-pharma-companies-2022-revenue